Araris Biotech raises CHF 15.2 mio in Seed financing round

06. November 2020

Araris Biotech Ltd has obtained CHF 15.2 million in a Seed financing round from the investors Pureos Bioventures, 4BIO Capital, btov Partners, Redalpine, VI Partners and Schroder Adveq.

Araris Biotech Ltd, a company pioneering antibody-drug conjugate (ADC)-linker technology, intends to use the proceeds to support advancement of lead ADCs into preclinical and clinical development. 



Araris Biotech Ltd was advised in all legal matters with regard to the Seed financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner), Denis A. Parvex (Associate) and Thomas Gysin (Associate).

Bader Gnehm & Partner has been repeatedly awarded as top law firm in the area of "Private Equity and Venture Capital".

The press release of Araris Biotech Ltd can be found here: Araris Biotech

BGP Berne is moving

12. October 2020

We are moving into new premises in the Länggasse!

As of 5 October 2020 you will find our Berne office at Länggassstrasse 10, 3012 Bern.

We kindly ask you to use our new mailing address from now on. Our phone and fax numbers as well as e-mail addresses remain unchanged.

Trade & Export Finance

13. July 2020

Bader Gnehm & Partner advised a Swiss exporter of disaster control equipment in the negotiation and conclusion of a complex, multi-staged sale and purchase transaction involving letter of credits, performance guarantees and several international parties, including inter alia a Swiss bank and a Chinese purchaser.

The Swiss exporter was advised in all legal matters by Bader Gnehm & Partner. The team was led by Oliver Gnehm (Partner) and furthermore included Denis A. Parvex (Associate).

Bader Gnehm & Partner’s Trade & Export Finance team features experienced specialists delivering comprehensive legal and negotiation services to market players and industries involved in international commerce, trade and export finance.

More information can be found here.

Bader Gnehm & Partner Ltd

02. June 2020

After more than 30 years as simple partnership, Bader Gnehm & Partner will be operating as a stock corporation as of June 1st, 2020.

The five founding partners Michael Bader, Oliver Gnehm, Elena Mégevand, Stefan Kunz and Olivier Bula are the new shareholders. Kathrin Straub will remain with Bader Gnehm & Partner Ltd as Of Counsel..

For the law firm, this is a further step in its modernisation. It will strengthen the cooperation across locations between the attorneys in Berne and Zurich and will place even greater emphasis on efficiency in our services.

We look forward to further exciting and successful years with our clients.


Exchange within LAWorld

28. April 2020

Our intern Mathura Maniyam had the chance to spend one month in our partner law firm Simons Muirhead & Burton LLP in London. During this time, she gained a valuable insight in a foreign legal culture and in the everyday work in a reputable law firm in London.

More information about the exchange can be found here.